These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8978757)

  • 21. L-deprenyl (selegiline) limits the repetitive firing of action potentials in rat hippocampal CA1 neurons via a dopaminergic mechanism.
    Huang CC; Tsai JJ; Hsu KS
    Brain Res; 1997 Apr; 753(1):27-35. PubMed ID: 9125428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage.
    Semkova I; Wolz P; Schilling M; Krieglstein J
    Eur J Pharmacol; 1996 Nov; 315(1):19-30. PubMed ID: 8960860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology and neuroprotective properties of rasagiline.
    Finberg JP; Lamensdorf I; Commissiong JW; Youdim MB
    J Neural Transm Suppl; 1996; 48():95-101. PubMed ID: 8988465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons.
    McKinley ET; Baranowski TC; Blavo DO; Cato C; Doan TN; Rubinstein AL
    Brain Res Mol Brain Res; 2005 Nov; 141(2):128-37. PubMed ID: 16209898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium.
    Koutsilieri E; Chen TS; Rausch WD; Riederer P
    Eur J Pharmacol; 1996 Jun; 306(1-3):181-6. PubMed ID: 8813631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective and neuronal rescue effects of selegiline: review.
    Magyar K; Haberle D
    Neurobiology (Bp); 1999; 7(2):175-90. PubMed ID: 10591051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
    Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
    J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J
    Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of R-(-)-deprenyl in adhesion of neuronal and non-neuronal cells].
    Jenei V; Zor K; Magyar K; Jakus J
    Orv Hetil; 2005 Mar; 146(13):601-6. PubMed ID: 15856624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. R-deprenyl: pharmacological spectrum of its activity.
    Magyar K; Szende B; Jenei V; Tábi T; Pálfi M; Szöko E
    Neurochem Res; 2010 Dec; 35(12):1922-32. PubMed ID: 20725780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins.
    Kotake Y; Taguchi R; Okuda K; Sekiya Y; Tasaki Y; Hirobe M; Ohta S
    Brain Res; 2005 Feb; 1033(2):143-50. PubMed ID: 15694918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiological effects of monoamine oxidase inhibition on rat midbrain dopaminergic neurones: an in vitro study.
    Mercuri NB; Bonci A; Siniscalchi A; Stefani A; Calabresi P; Bernardi G
    Br J Pharmacol; 1996 Feb; 117(3):528-532. PubMed ID: 8821544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apomorphine offers new insight into dopaminergic neuron vulnerability in mesencephalic cultures.
    Vaglini F; Pardini C; Viaggi C; Caramelli A; Corsini GU
    Neuropharmacology; 2008 Oct; 55(5):737-42. PubMed ID: 18634808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells.
    Lai CT; Yu PH
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):186-91. PubMed ID: 9007048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacology of selegiline.
    Magyar K
    Int Rev Neurobiol; 2011; 100():65-84. PubMed ID: 21971003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased neuronal cell survival after L-deprenyl treatment in experimental thiamine deficiency.
    Todd KG; Butterworth RF
    J Neurosci Res; 1998 Apr; 52(2):240-6. PubMed ID: 9579414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurorescuing effects of the GAPDH ligand CGP 3466B.
    Waldmeier PC; Boulton AA; Cools AR; Kato AC; Tatton WG
    J Neural Transm Suppl; 2000; (60):197-214. PubMed ID: 11205140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective aspects of a novel MAO-B inhibitor PF9601N.
    Pérez V; Morón J; Pastó M; Unzeta M
    Neurobiology (Bp); 2000; 8(3-4):231-6. PubMed ID: 11225513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDP-choline reduces dopaminergic cell loss induced by MPP(+) and glutamate in primary mesencephalic cell culture.
    Radad K; Gille G; Xiaojing J; Durany N; Rausch WD
    Int J Neurosci; 2007 Jul; 117(7):985-98. PubMed ID: 17613109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.